Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What level of CAGR-driven expansion is anticipated in the Infectious Disease Molecular Diagnostics Market between 2026 and 2030?
The infectious disease molecular diagnostics market has experienced significant expansion in recent years. Its valuation is anticipated to increase from $30.46 billion in 2025 to $32.04 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.2%. This historical development can be ascribed to several factors, including the rising occurrence of infectious diseases, breakthroughs in PCR and sequencing technologies, augmented government financial support for infectious disease research, a heightened understanding of the benefits of early diagnosis, and the growth of clinical laboratories.
The market for infectious disease molecular diagnostics is projected to experience consistent expansion in the coming years. This market is anticipated to reach a valuation of $38.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Several factors will fuel this growth during the forecast period, including the increasing integration of AI-powered diagnostic tools, a surge in the need for quick and precise diagnostics, the development of healthcare infrastructure in emerging markets, a heightened emphasis on personalized medical approaches, and the proliferation of at-home molecular diagnostic solutions. Key trends anticipated within this timeframe involve the widespread embrace of rapid point-of-care diagnostics, an escalating requirement for multiplex testing, the incorporation of molecular diagnostics into electronic health record (EHR) systems, the expansion of initiatives for infectious disease surveillance, and a growing emphasis on identifying antimicrobial resistance.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp
What Drivers Are Affecting Demand-Supply Dynamics In The Infectious Disease Molecular Diagnostics Market?
The future expansion of the infectious disease molecular diagnostics market is anticipated to be driven by the rising occurrence of infectious diseases. These diseases are ailments resulting from pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, capable of direct or indirect transmission between individuals. The escalating incidence of infectious diseases largely stems from globalization and heightened travel, which facilitates the swift cross-border dissemination of pathogens, transforming localized outbreaks into worldwide health crises. By providing quick and precise identification of pathogens at their genetic level, infectious disease molecular diagnostics aid in managing infectious diseases, thereby promoting prompt diagnosis, precise treatment, and successful control of outbreaks. As an illustration, the US Centers for Disease Control and Prevention (CDC), a US-based government body, reported in November 2024 that tuberculosis (TB) cases in 2023 climbed to 9,633 from 8,332 in 2022, representing a 15.6% rise in the number of cases. Consequently, the expanding occurrence of infectious diseases is a key factor propelling the growth of the infectious disease molecular diagnostics market.
How Is The Infectious Disease Molecular Diagnostics Market Organized Into Various Segments?
The infectious disease molecular diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software And Services
2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies
3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications
4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits
2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services
How Are Emerging Trends Affecting The Progression Of The Infectious Disease Molecular Diagnostics Market?
Leading companies active in the infectious disease molecular diagnostics market are concentrating on creating innovative solutions, such as real-time polymerase chain reaction kits, to enable the rapid, accurate, and high-throughput identification of infectious pathogens. Real-time polymerase chain reaction (PCR) kits are diagnostic instruments designed to amplify and concurrently detect specific genetic material of pathogens in real time, thereby allowing for the prompt and precise identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, introduced Applied Biosystems TaqPath polymerase chain reaction kits, specifically developed for the detection of infectious diseases in India. These kits represent fast, highly sensitive multiplex diagnostic solutions that facilitate real-time polymerase chain reaction detection of infectious disease targets using a comprehensive workflow, from ribonucleic acid extraction to diagnostic report generation, typically completed in under 4 hours. Furthermore, these kits incorporate multiplexed assays targeting multiple genomic regions of pathogens, include internal process controls, and provide automated data interpretation, which reduces user error and enhances the reliability of the results.
Who Are The Major Companies Operating In The Infectious Disease Molecular Diagnostics Market?
Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.
Access The Complete Report For Deeper Market Insights:
Which Global Regions Are Shaping The Competitive Landscape Of The Infectious Disease Molecular Diagnostics Market?
North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Infectious Disease Molecular Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2026, By The Business Research Company
Infection Control Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Infection Prevention Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report
Hospital Acquired Infection Control Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company